HCPCS code J0887: Epoetin beta, per 1 mcg, ESRD2026 Medicare rate & RVUs in Washington
Reports epoetin beta given to a patient with end-stage renal disease on dialysis to treat anemia associated with chronic kidney disease.
CMS doesn’t publish an office rate for J0887 in Washington.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J0887 covers
This code identifies methoxy polyethylene glycol-epoetin beta, a long-acting medicine that stimulates red blood cell production. It is used to treat anemia associated with chronic kidney disease in patients with end-stage renal disease who are receiving dialysis. Dialysis facilities and other clinicians who administer the drug may report it. The drug is given intravenously or subcutaneously.
Medicare excludes this code from the physician fee schedule under status E. When Medicare covers the drug, payment is set by the Medicare contractor under the HCPCS other-contractor-pricing method; special Medicare coverage instructions apply. Each unit represents 1 mcg of epoetin beta, so report units based on the total dose administered in micrograms. J0888 is the corresponding epoetin beta code for non-ESRD use; use the code matching the patient’s condition and dialysis status.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J0887 pays more and less in Washington
| Payment locality | Office | Facility |
|---|---|---|
| King County, WA | Unavailable | Unavailable |
| Rest of Washington | Unavailable | Unavailable |
How the J0887 rate is calculated
Each of J0887’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J0887
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J0887
J0887 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J0887
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J0887 isn’t priced in this setting.
J0887 compared with similar codes
Compare codes · National
5 codes, side by side
How to choose
- J0888Epoetin betaPer 1 mcg
- Both identify epoetin beta, but this code is for ESRD patients on dialysis; J0888 is for non-ESRD use.
- J0882Darbepoetin alfaESRD on dialysis, per 1 mcg
- J0882 identifies darbepoetin alfa for ESRD patients on dialysis. This code identifies epoetin beta for that patient group.
- J0885Epoetin alfaPer 1,000 units
- J0885 is for epoetin alfa in non-ESRD use. This code is for epoetin beta in ESRD patients on dialysis.
- J0881Darbepoetin alfaPer 1 mcg, non-ESRD
- J0881 identifies darbepoetin alfa for non-ESRD use; this code is epoetin beta for ESRD patients on dialysis.
J0887 billing questions
When should I use this code rather than J0888?
Use this code for epoetin beta administered for a patient with ESRD on dialysis. J0888 is the non-ESRD code for epoetin beta.
How many units should I report?
One unit represents 1 mcg. Calculate units from the total epoetin beta dose administered in micrograms.
What does Medicare status E mean for this code?
CMS excludes it from the physician fee schedule. When Medicare covers the drug, the Medicare contractor sets payment under the other-contractor-pricing method.
Does this code identify epoetin alfa?
No. This code is for epoetin beta; J0885 identifies epoetin alfa for non-ESRD use.
What condition and patient population does this code describe?
It describes epoetin beta used to treat anemia associated with chronic kidney disease in a patient with ESRD receiving dialysis.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J0887 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist